Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Ending Cash Balance (2024 - 2026)

Updated

Drugs Made In America Acquisition's Ending Cash Balance came in at $20,280 for Q2 2026, compared with $822.00 a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Ending Cash Balance (2024 - 2026) Analysis & Trends

For FY2025, Drugs Made In America Acquisition's Ending Cash Balance was $6,137, up 354.3% from FY2024.

  • Going back by year, Ending Cash Balance was $1,351 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 12.90 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - 3.27 Bn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 22.64 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 688.00 Mn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn 22.85 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 145.80 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 597.71 Mn
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - 20,280.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20,280.00
Mar 31, 2026 14,887.00
Dec 31, 2025 6,137.00
Sep 30, 2025 1,351.00
Jun 30, 2025 822.00
Mar 31, 2025 822.00
Dec 31, 2024 1,351.00
Sep 30, 2024 2,095.00
API Access

Drugs Made In America Acquisition Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=DMAA&period=max&api_key=YOUR_API_KEY